The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.

HCA Healthcare raises 2025 profit forecast amidst insurance uncertainty while Centene anticipates a 2026 profitability boost ...

The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and its ...

Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Sarepta maintains it reported the incident to the FDA in June, and the boy's doctor had deemed his death was unrelated to treatment.

Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain ...